Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites

NCT01052610 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Bronchial Asthma
Allergic Rhinitis

Interventions

DRUG: sublingual house dust mites allergen extract
DRUG: placebo in sublingual applicator

Sponsor

Medical University of Lodz